dc.contributor.author | Rust, Kelly | |
dc.contributor.author | Spiliopoulou, Pavlina | |
dc.contributor.author | Tang, Chee Yuan | |
dc.contributor.author | Bell, Christine | |
dc.contributor.author | Stirling, Diane | |
dc.contributor.author | Phang, Tze Hui Fifi | |
dc.contributor.author | Davidson, Rosemarie | |
dc.contributor.author | Mackean, Melanie | |
dc.contributor.author | Nussey, Fiona | |
dc.contributor.author | Glasspool, Ros | |
dc.contributor.author | Reed, Nick | |
dc.contributor.author | Sadozye, Azmat | |
dc.contributor.author | Porteous, Mary | |
dc.contributor.author | McGoldrick, Trevor | |
dc.contributor.author | Ferguson, Michelle | |
dc.contributor.author | Miedzybrodzka, Zofia | |
dc.contributor.author | McNeish, Iain A | |
dc.contributor.author | Gourley, Charlie | |
dc.date.accessioned | 2019-05-09T23:03:21Z | |
dc.date.available | 2019-05-09T23:03:21Z | |
dc.date.issued | 2018-10 | |
dc.identifier.citation | Rust , K , Spiliopoulou , P , Tang , C Y , Bell , C , Stirling , D , Phang , T H F , Davidson , R , Mackean , M , Nussey , F , Glasspool , R , Reed , N , Sadozye , A , Porteous , M , McGoldrick , T , Ferguson , M , Miedzybrodzka , Z , McNeish , I A & Gourley , C 2018 , ' Routine germline BRCA1 and BRCA2 testing in ovarian carcinoma patients : analysis of the Scottish real life experience ' , BJOG-An International Journal of Obstetrics and Gynaecology , vol. 125 , no. 11 , pp. 1451-1458 . https://doi.org/10.1111/1471-0528.15171 | en |
dc.identifier.issn | 1470-0328 | |
dc.identifier.other | PURE: 116468632 | |
dc.identifier.other | PURE UUID: 27ea0563-4cbb-499a-b821-257421dff89a | |
dc.identifier.other | PubMed: 29460478 | |
dc.identifier.other | Scopus: 85046768566 | |
dc.identifier.other | WOS: 000444409100024 | |
dc.identifier.uri | http://hdl.handle.net/2164/12250 | |
dc.description | Funding Information Edinburgh Ovarian Cancer Database Cancer Research UK | en |
dc.format.extent | 8 | |
dc.language.iso | eng | |
dc.relation.ispartof | BJOG-An International Journal of Obstetrics and Gynaecology | en |
dc.rights | This is the peer reviewed version of the following article:Rust K, Spiliopoulou P, Tang CY, Bell C, Stirling D, Phang THF, Davidson R, Mackean M, Nussey F, Glasspool RM, Reed NS, Sadozye A, Porteous M, McGoldrick T, Ferguson M, Miedzybrodzka Z, McNeish IA, Gourley C. Routine germline BRCA1 and BRCA2 testing in patients with ovarian carcinoma: analysis of the Scottish real‐life experience. BJOG 2018; 125:1451–1458., which has been published in final form at DOI: 10.1111/1471-0528.15171. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving. | en |
dc.subject | Journal Article | en |
dc.subject | BRCA1 | en |
dc.subject | BRCA2 | en |
dc.subject | RAD51C | en |
dc.subject | RAD51D | en |
dc.subject | ovarian cancer | en |
dc.subject | R Medicine | en |
dc.subject.lcc | R | en |
dc.title | Routine germline BRCA1 and BRCA2 testing in ovarian carcinoma patients : analysis of the Scottish real life experience | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Applied Medicine | en |
dc.contributor.institution | University of Aberdeen.Data Safe Haven | en |
dc.contributor.institution | University of Aberdeen.Institute of Medical Sciences | en |
dc.contributor.institution | University of Aberdeen.Clinical Medicine | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Postprint | en |
dc.identifier.doi | https://doi.org/10.1111/1471-0528.15171 | |
dc.date.embargoedUntil | 2019-05-10 | |